Developer docs
API playgroundTry for free, no card

Search company profiles

The LOOP Zurich

Full company profile

uuid00399dq

Namestring
The LOOP Zurich
Legal namestring
The LOOP Zurich
Company typeenum
Private
Founded yearint
2020
Descriptiontext

The LOOP Zurich is a Swiss non-profit translational research consortium, organized as a simple partnership (Einfache Gesellschaft) under Swiss law, that links the biomedical and bioinformatics capacity of ETH Zurich and the University of Zurich with the clinical research operations of four Zurich university hospitals: University Hospital Zurich (USZ), University Children's Hospital Zurich (KiSpi), Balgrist University Hospital, and the University Hospital of Psychiatry Zurich (PUK). Founded operationally in 2020 and headquartered at Moussonstrasse 15 in Zurich, the organization employs 51–100 staff in its managing office and orchestrates an estimated 18–25 researchers per major project across the six partner institutions. Its mission is to accelerate the translation of molecular and computational discoveries into precision-medicine applications for patient benefit.

The consortium's central technology asset is the LOOP BMIP (Biomedical Informatics Platform), a shared research infrastructure that integrates and harmonizes clinical data from the partner hospitals and universities with interoperability to the national Swiss Personalized Health Network (SPHN). The BMIP is extended by two Platform Projects—POLAR, which pipelines proteomic profiles of lymphomas into clinical reporting, and BMI2, which extends the platform to medical imaging data across radiology, pathology, and radiation oncology. The translational portfolio comprises StimuLOOP (precision sensorimotor neurorehabilitation for stroke and Parkinson's), INTeRCePT (ex vivo drug response profiling to intercept clonal evolution in blood cancers), LOOBesity (molecular and AI-driven personalization of obesity therapy, including a GLP-1 Decision Support System), and mTORUS (microbiome-based therapies for recurrent urinary tract infections). Incubator Projects (AI Tumor Board, PREVENT-SSc) and the cross-institutional Zurich Precision Oncology Consortium (ZPOC) provide a pipeline of new initiatives, with two additional translational projects (ReGenStent in cardiovascular; AU-FUS Brain Networks in neuropharmacology) selected to start in late 2026.

The LOOP Zurich does not sell commercial products or services. It is funded through donations from a concentrated set of Swiss foundations (notably Helmut Horten Foundation, Vontobel-Stiftung, Monique Dornonville de la Cour-Foundation, Uniscientia Foundation, Georg und Berta Schwyzer-Winiker Foundation, and Promedica Foundation) plus competitive internal grant calls (Translational Projects up to CHF 5M over five years; Platform and Incubator Projects up to CHF 1M over three years). Governance comprises a Directorate (Founding Director/CEO Markus Rudin; Co-Director Giatgen Spinas; Managing Director/COO Jens Selige), a Steering Committee with senior representatives from each of the six partner institutions, and an international Scientific Advisory Board. Distribution occurs through peer-reviewed publications (50+ papers including in Nature Cancer, Science, Blood, and Nature Communications), conference presentations (ASH, EHA, ICNR), integration into partner-hospital clinical workflows, annual reports (2023–2025 published), a podcast and YouTube channel, and co-development partnerships with EMBL Heidelberg, EPFL, TU München, IRB Bellinzona, IOR Bellinzona, and cereneo.

Short descriptiontext

The LOOP Zurich is a Swiss non-profit translational research consortium linking ETH Zurich, University of Zurich, and four Zurich university hospitals to advance precision medicine. It operates the LOOP BMIP shared biomedical informatics platform and funds multi-institutional translational projects in oncology, neurology, obesity, and infectious disease.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersZürich, Switzerland
HQ citystring
Zürich
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
translational research, precision medicine, biomedical informatics, clinical research consortium, medical data infrastructure
Industry4 codes
PRIMARYHLAIALAF
Translational Medicine & Biomarkers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Translational Research
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Foundation Funding
TypeManaged Services
Description

The LOOP Zurich operates as a research consortium funded primarily through donations from multiple foundations supporting precision medicine research and development.

theloopzurich.ch
2Project Grants
TypeManaged Services
Description

Funding through competitive grant calls: Platform Projects (max CHF 1 million over 3 years), Translational Projects (up to CHF 5 million over 5 years), Incubator Projects (max CHF 1 million over 3 years).

theloopzurich.ch
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The LOOP Zurich operates as a translational research consortium that develops and operates the LOOP BMIP biomedical informatics platform, integrating clinical data from Zurich's university hospitals for data-driven precision medicine research. It delivers this through three program tracks: Platform Projects (BMI2 imaging, POLAR proteomics), Translational Projects (INTeRCePT blood cancer, StimuLOOP neurorehabilitation, LOOBesity obesity, mTORUS urinary tract infections), and Incubator Projects (AI Tumor Board, PREVENT-SSc), combined with the ZPOC oncology consortium. All outputs are research capabilities used by partner institutions rather than commercial products sold externally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Goal to increase patient therapy response rates by 50% through INTeRCePT precision oncology approach
+4 more records
Product overview1 text field

The LOOP Zurich operates as a translational research center focused on precision medicine, connecting biomedical research and bioinformatics from ETH Zurich and University of Zurich with clinical research from four university hospitals. Its core product is the LOOP BMIP (Biomedical Informatics Platform), a shared research infrastructure that consolidates clinical data and supports data-driven research. The portfolio includes Platform Projects (BMI2 for imaging integration, POLAR for proteomics), Translational Projects (INTeRCePT for blood cancer, StimuLOOP for neurorehabilitation, LOOBesity for obesity treatment, mTORUS for urinary infections), and Incubator Projects (AI Tumor Board for oncology decision support). ZPOC coordinates precision oncology across institutions. All offerings are research-focused rather than commercial products.

Product and service9 records
1LOOP BMIP (Biomedical Informatics Platform)
CategoryCore Platform
Description

Shared research infrastructure that integrates, stores, and harmonizes clinical data from Zurich's university hospitals and makes it accessible for interdisciplinary, data-driven research in precision medicine, with SPHN interoperability.

2BMI2 (Biomedical Informatics Imaging Platform)
CategoryPlatform Project
Description

SPHN-compatible extension of LOOP BMIP that integrates medical imaging data from radiology, pathology, radiation oncology, and other disciplines, making it available for AI-supported analysis and research.

3POLAR (ProteOmics for Lymphoma and Prognostication)
CategoryPlatform Project
Description

Workflow and analysis pipeline that integrates lymphoma proteomes into the LOOP BMIP for diagnosis, identifying treatment targets, and assessing drug effectiveness, supported by the Uniscientia Foundation.

4INTeRCePT (Intercepting Clonal Evolution in Blood Cancers)
CategoryTranslational Project
Description

Translational project developing an ex vivo drug testing program and INTeRCePT Assay for personalized treatment optimization in hematologic malignancies, with the goal of increasing patient therapy response rates by 50%.

5StimuLOOP (Precision Sensorimotor Neurorehabilitation)
CategoryTranslational Project
Description

Translational project developing personalized stimulation loops using visual feedback, acoustic stimulation, and EEG-synchronized sleep stimulation for precision neurorehabilitation of stroke and Parkinson's patients.

6LOOBesity (Precision Medicine in Obesity)
CategoryTranslational Project
Description

Translational project advancing precision medicine in obesity by integrating molecular, imaging, and AI-driven analyses to develop personalized therapies for individuals with altered glucocorticoid metabolism.

7mTORUS (Microbiome Therapy for Recurrent Urinary Tract Infections)
CategoryTranslational Project
Description

Microbiome-based therapeutic project developing treatment options for recurrent urinary tract infections through bacteriophage elimination and microbiome transplantation, supported by the Monique Dornonville de la Cour-Foundation.

8AI Tumor Board (Personalized Decision Support in Precision Oncology)
CategoryIncubator Project
Description

AI-powered platform providing oncologists with evidence-based treatment recommendations by aligning patient data with medical guidelines and analyzing historical treatment outcomes in precision oncology.

9ZPOC (Zurich Precision Oncology Consortium)
CategoryResearch Consortium
Description

Jointly selected consortium by CCCZ, TPC, and The LOOP Zurich that supports interdisciplinary teams developing innovative diagnostic and therapeutic approaches for precision oncology.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1EMBL Heidelberg
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International research partner contributing to INTeRCePT blood cancer project. Prof. Wolfgang Huber from EMBL leads quantitative biology and statistics work package.

theloopzurich.ch
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Neurorehabilitation clinic in Vitznau collaborating on StimuLOOP project development and knowledge exchange.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Swiss technical university partner in mTORUS project contributing to microbiome research.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Technical University of Munich collaborating partner in LOOBesity obesity research project.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Ticino-based research institution collaborating on Helmut Horten Anniversary Project extending INTeRCePT to rare lymphomas research.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Ticino-based oncology research institution partnering on Helmut Horten Anniversary Project for precision medicine in lymphoma.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Major U.S. biomedical research institute focused on genomics, precision medicine, and translational science with multi-institutional academic anchoring. Operates a comparable model of integrating computational biology with clinical research across partner hospitals.

TypeDirect peer
Description

Genome and biomedical research institute with foundation funding (Wellcome Trust) focused on translational genomics and precision medicine. Similar in combining large-scale data infrastructure with translational projects targeting specific disease areas.

TypeDirect peer
Description

Non-profit medical research organization focused on large-scale science programs with multi-institutional collaboration and substantial foundation funding. Similar structure of operating major research programs with shared data infrastructure and high-impact publication output.

TypeDirect peer
Description

U.K.-based biomedical discovery institute with multi-institutional academic affiliation focused on translational research. Comparable scale and partnership structure bringing together basic and clinical research under one organizational umbrella.

TypeRegional player
Description

Swedish national molecular life sciences consortium distributed across multiple universities, providing shared technology platforms and data infrastructure. Comparable consortium model operating across national academic and hospital partners for life science research.

TypeDirect peer
Description

Large-scale precision oncology translational initiative within MD Anderson Cancer Center. Directly comparable to INTeRCePT and ZPOC projects in scope of multi-project, multi-institutional precision cancer research with strong foundation/philanthropic backing.

TypeDirect peer
Description

Translational research consortium at Charité and Max Delbrück Center, also bridging university hospitals with biomedical research. Operates a similar precision medicine and clinical translation model funded by German federal and state governments.

TypeDirect peer
Description

Translational genomics institute within Mount Sinai Health System focused on precision medicine and biomedical informatics. Comparable focus on AI/ML-driven clinical research and integration of hospital data with research platforms.

9National Center for Tumor Diseases (NCT)
TypeDirect peer
Description

German translational oncology consortium integrating multiple university hospitals with research institutions. Direct peer in structure of cross-institutional translational precision oncology research with foundation and government funding.

10Swiss Institute of Bioinformatics (SIB)
TypeDirect peer
Description

Swiss national bioinformatics organization coordinating data infrastructure and computational biology across Swiss academic institutions. Closest peer to The LOOP Zurich's LOOP BMIP platform component and SPHN interoperability mission.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles18 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The LOOP Zurich

Translational Researchtheloopzurich.ch

The LOOP Zurich is a Swiss non-profit translational research consortium linking ETH Zurich, University of Zurich, and four Zurich university hospitals to advance precision medicine. It operates the LOOP BMIP shared biomedical informatics platform and funds multi-institutional translational projects in oncology, neurology, obesity, and infectious disease.

What The LOOP Zurich does

The LOOP Zurich is a Swiss non-profit translational research consortium, organized as a simple partnership (Einfache Gesellschaft) under Swiss law, that links the biomedical and bioinformatics capacity of ETH Zurich and the University of Zurich with the clinical research operations of four Zurich university hospitals: University Hospital Zurich (USZ), University Children's Hospital Zurich (KiSpi), Balgrist University Hospital, and the University Hospital of Psychiatry Zurich (PUK). Founded operationally in 2020 and headquartered at Moussonstrasse 15 in Zurich, the organization employs 51–100 staff in its managing office and orchestrates an estimated 18–25 researchers per major project across the six partner institutions. Its mission is to accelerate the translation of molecular and computational discoveries into precision-medicine applications for patient benefit.

The consortium's central technology asset is the LOOP BMIP (Biomedical Informatics Platform), a shared research infrastructure that integrates and harmonizes clinical data from the partner hospitals and universities with interoperability to the national Swiss Personalized Health Network (SPHN). The BMIP is extended by two Platform Projects—POLAR, which pipelines proteomic profiles of lymphomas into clinical reporting, and BMI2, which extends the platform to medical imaging data across radiology, pathology, and radiation oncology. The translational portfolio comprises StimuLOOP (precision sensorimotor neurorehabilitation for stroke and Parkinson's), INTeRCePT (ex vivo drug response profiling to intercept clonal evolution in blood cancers), LOOBesity (molecular and AI-driven personalization of obesity therapy, including a GLP-1 Decision Support System), and mTORUS (microbiome-based therapies for recurrent urinary tract infections). Incubator Projects (AI Tumor Board, PREVENT-SSc) and the cross-institutional Zurich Precision Oncology Consortium (ZPOC) provide a pipeline of new initiatives, with two additional translational projects (ReGenStent in cardiovascular; AU-FUS Brain Networks in neuropharmacology) selected to start in late 2026.

The LOOP Zurich does not sell commercial products or services. It is funded through donations from a concentrated set of Swiss foundations (notably Helmut Horten Foundation, Vontobel-Stiftung, Monique Dornonville de la Cour-Foundation, Uniscientia Foundation, Georg und Berta Schwyzer-Winiker Foundation, and Promedica Foundation) plus competitive internal grant calls (Translational Projects up to CHF 5M over five years; Platform and Incubator Projects up to CHF 1M over three years). Governance comprises a Directorate (Founding Director/CEO Markus Rudin; Co-Director Giatgen Spinas; Managing Director/COO Jens Selige), a Steering Committee with senior representatives from each of the six partner institutions, and an international Scientific Advisory Board. Distribution occurs through peer-reviewed publications (50+ papers including in Nature Cancer, Science, Blood, and Nature Communications), conference presentations (ASH, EHA, ICNR), integration into partner-hospital clinical workflows, annual reports (2023–2025 published), a podcast and YouTube channel, and co-development partnerships with EMBL Heidelberg, EPFL, TU München, IRB Bellinzona, IOR Bellinzona, and cereneo.

The LOOP Zurich firmographics

Firmographics
Name
The LOOP Zurich
Legal name
The LOOP Zurich
Website
https://theloopzurich.ch
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
The LOOP Zurich is a Swiss non-profit translational research consortium linking ETH Zurich, University of Zurich, and four Zurich university hospitals to advance precision medicine. It operates the LOOP BMIP shared biomedical informatics platform and funds multi-institutional translational projects in oncology, neurology, obesity, and infectious disease.
Ownership category
akta.pro rank

The LOOP Zurich industry classification

Industry
Product category
Translational Research
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAIALAF
Translational Medicine & Biomarkers
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)

Keywords

  • Translational research
  • Precision medicine
  • Biomedical informatics
  • Clinical research consortium
  • Medical data infrastructure

Where The LOOP Zurich is headquartered

Location

Headquarters

HQ city
Zürich
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

The LOOP Zurich business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

  1. Foundation Funding: The LOOP Zurich operates as a research consortium funded primarily through donations from multiple foundations supporting precision medicine research and development.
  2. Project Grants: Funding through competitive grant calls: Platform Projects (max CHF 1 million over 3 years), Translational Projects (up to CHF 5 million over 5 years), Incubator Projects (max CHF 1 million over 3 years).

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

The LOOP Zurich product offering

Product offering

Core offering

The LOOP Zurich operates as a translational research consortium that develops and operates the LOOP BMIP biomedical informatics platform, integrating clinical data from Zurich's university hospitals for data-driven precision medicine research. It delivers this through three program tracks: Platform Projects (BMI2 imaging, POLAR proteomics), Translational Projects (INTeRCePT blood cancer, StimuLOOP neurorehabilitation, LOOBesity obesity, mTORUS urinary tract infections), and Incubator Projects (AI Tumor Board, PREVENT-SSc), combined with the ZPOC oncology consortium. All outputs are research capabilities used by partner institutions rather than commercial products sold externally.

Product overview

The LOOP Zurich operates as a translational research center focused on precision medicine, connecting biomedical research and bioinformatics from ETH Zurich and University of Zurich with clinical research from four university hospitals. Its core product is the LOOP BMIP (Biomedical Informatics Platform), a shared research infrastructure that consolidates clinical data and supports data-driven research. The portfolio includes Platform Projects (BMI2 for imaging integration, POLAR for proteomics), Translational Projects (INTeRCePT for blood cancer, StimuLOOP for neurorehabilitation, LOOBesity for obesity treatment, mTORUS for urinary infections), and Incubator Projects (AI Tumor Board for oncology decision support). ZPOC coordinates precision oncology across institutions. All offerings are research-focused rather than commercial products.

Differentiator

Problem solved

Functional benefit

Products and services

  • LOOP BMIP (Biomedical Informatics Platform) Shared research infrastructure that integrates, stores, and harmonizes clinical data from Zurich's university hospitals and makes it accessible for interdisciplinary, data-driven research in precision medicine, with SPHN interoperability.
  • BMI2 (Biomedical Informatics Imaging Platform) SPHN-compatible extension of LOOP BMIP that integrates medical imaging data from radiology, pathology, radiation oncology, and other disciplines, making it available for AI-supported analysis and research.
  • POLAR (ProteOmics for Lymphoma and Prognostication) Workflow and analysis pipeline that integrates lymphoma proteomes into the LOOP BMIP for diagnosis, identifying treatment targets, and assessing drug effectiveness, supported by the Uniscientia Foundation.
  • INTeRCePT (Intercepting Clonal Evolution in Blood Cancers) Translational project developing an ex vivo drug testing program and INTeRCePT Assay for personalized treatment optimization in hematologic malignancies, with the goal of increasing patient therapy response rates by 50%.
  • StimuLOOP (Precision Sensorimotor Neurorehabilitation) Translational project developing personalized stimulation loops using visual feedback, acoustic stimulation, and EEG-synchronized sleep stimulation for precision neurorehabilitation of stroke and Parkinson's patients.
  • LOOBesity (Precision Medicine in Obesity) Translational project advancing precision medicine in obesity by integrating molecular, imaging, and AI-driven analyses to develop personalized therapies for individuals with altered glucocorticoid metabolism.
  • mTORUS (Microbiome Therapy for Recurrent Urinary Tract Infections) Microbiome-based therapeutic project developing treatment options for recurrent urinary tract infections through bacteriophage elimination and microbiome transplantation, supported by the Monique Dornonville de la Cour-Foundation.
  • AI Tumor Board (Personalized Decision Support in Precision Oncology) AI-powered platform providing oncologists with evidence-based treatment recommendations by aligning patient data with medical guidelines and analyzing historical treatment outcomes in precision oncology.
  • ZPOC (Zurich Precision Oncology Consortium) Jointly selected consortium by CCCZ, TPC, and The LOOP Zurich that supports interdisciplinary teams developing innovative diagnostic and therapeutic approaches for precision oncology.

Quantifiable outcome

  • Goal to increase patient therapy response rates by 50% through INTeRCePT precision oncology approach
  • +4 more outcomes

Companies that use The LOOP Zurich

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles3 records

The LOOP Zurich technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

The LOOP Zurich partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and supporting.

  • EMBL HeidelbergcoreStrategic or Co-development PartnerInternational research partner contributing to INTeRCePT blood cancer project. Prof. Wolfgang Huber from EMBL leads quantitative biology and statistics work package.
  • cereneosupportingStrategic or Co-development PartnerNeurorehabilitation clinic in Vitznau collaborating on StimuLOOP project development and knowledge exchange.
  • EPFLsupportingStrategic or Co-development PartnerSwiss technical university partner in mTORUS project contributing to microbiome research.
  • TU MünchensupportingStrategic or Co-development PartnerTechnical University of Munich collaborating partner in LOOBesity obesity research project.
  • Institute for Research in Biomedicine (IRB Bellinzona)supportingStrategic or Co-development PartnerTicino-based research institution collaborating on Helmut Horten Anniversary Project extending INTeRCePT to rare lymphomas research.
  • Institute of Oncology Research (IOR Bellinzona)supportingStrategic or Co-development PartnerTicino-based oncology research institution partnering on Helmut Horten Anniversary Project for precision medicine in lymphoma.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

The LOOP Zurich competitors and assessment

Company assessment

Direct peers

  • Broad Institute of MIT and Harvard: Major U.S. biomedical research institute focused on genomics, precision medicine, and translational science with multi-institutional academic anchoring. Operates a comparable model of integrating computational biology with clinical research across partner hospitals.
  • Wellcome Sanger Institute: Genome and biomedical research institute with foundation funding (Wellcome Trust) focused on translational genomics and precision medicine. Similar in combining large-scale data infrastructure with translational projects targeting specific disease areas.
  • Allen Institute: Non-profit medical research organization focused on large-scale science programs with multi-institutional collaboration and substantial foundation funding. Similar structure of operating major research programs with shared data infrastructure and high-impact publication output.
  • Francis Crick Institute: U.K.-based biomedical discovery institute with multi-institutional academic affiliation focused on translational research. Comparable scale and partnership structure bringing together basic and clinical research under one organizational umbrella.
  • MD Anderson Moon Shots Program: Large-scale precision oncology translational initiative within MD Anderson Cancer Center. Directly comparable to INTeRCePT and ZPOC projects in scope of multi-project, multi-institutional precision cancer research with strong foundation/philanthropic backing.
  • Berlin Institute of Health (BIH): Translational research consortium at Charité and Max Delbrück Center, also bridging university hospitals with biomedical research. Operates a similar precision medicine and clinical translation model funded by German federal and state governments.
  • Icahn Institute for Genomics and Multiscale Biology: Translational genomics institute within Mount Sinai Health System focused on precision medicine and biomedical informatics. Comparable focus on AI/ML-driven clinical research and integration of hospital data with research platforms.
  • National Center for Tumor Diseases (NCT): German translational oncology consortium integrating multiple university hospitals with research institutions. Direct peer in structure of cross-institutional translational precision oncology research with foundation and government funding.
  • Swiss Institute of Bioinformatics (SIB): Swiss national bioinformatics organization coordinating data infrastructure and computational biology across Swiss academic institutions. Closest peer to The LOOP Zurich's LOOP BMIP platform component and SPHN interoperability mission.

Regional players

  • SciLifeLab: Swedish national molecular life sciences consortium distributed across multiple universities, providing shared technology platforms and data infrastructure. Comparable consortium model operating across national academic and hospital partners for life science research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

The LOOP Zurich social profiles

Digital presence

The LOOP Zurich financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The LOOP Zurich leadership team

Management profile

Number of profiles

Profiles18 records

The LOOP Zurich funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The LOOP Zurich M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The LOOP Zurich

What does The LOOP Zurich do?

The LOOP Zurich operates as a translational research consortium that develops and operates the LOOP BMIP biomedical informatics platform, integrating clinical data from Zurich's university hospitals for data-driven precision medicine research. It delivers this through three program tracks: Platform Projects (BMI2 imaging, POLAR proteomics), Translational Projects (INTeRCePT blood cancer, StimuLOOP neurorehabilitation, LOOBesity obesity, mTORUS urinary tract infections), and Incubator Projects (AI Tumor Board, PREVENT-SSc), combined with the ZPOC oncology consortium. All outputs are research capabilities used by partner institutions rather than commercial products sold externally.

Is The LOOP Zurich a public or private company?

The LOOP Zurich is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The LOOP Zurich founded?

The LOOP Zurich was founded in 2020. It employs 1 to 10 people.

Where is The LOOP Zurich based?

The LOOP Zurich is headquartered in Zürich, Switzerland, in the Europe region.

How does The LOOP Zurich make money?

Two revenue lines are on record. Foundation Funding is the primary driver. The others are project Grants.

Who are The LOOP Zurich's main competitors?

Direct peers on record are Broad Institute of MIT and Harvard, Wellcome Sanger Institute, Allen Institute, Francis Crick Institute, MD Anderson Moon Shots Program, Berlin Institute of Health (BIH), Icahn Institute for Genomics and Multiscale Biology, National Center for Tumor Diseases (NCT) and Swiss Institute of Bioinformatics (SIB). SciLifeLab is listed as a regional player.

Does The LOOP Zurich have an API?

No public API is recorded for The LOOP Zurich.

What industry is The LOOP Zurich in?

The LOOP Zurich's product category is Translational Research. Its primary akta.pro industry code is HLAIALAF, Translational Medicine & Biomarkers, with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals